Providing magnesium sulfate to pregnant patients before delivery in the periviable period of 22-24 weeks’ gestation was not linked to better neurodevelopmental outcomes in the newborn after accounting ...

Amneal Pharmaceuticals is recalling Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, Lot AH250162.

Critical gaps in eclampsia care persist despite declining rates in high-income countries; many women have seizures without prior preeclampsia, some miss treatment, and some have seizures postpartum.

Magnesium sulfate given intravenously to pregnant women at risk of very preterm birth was not associated with benefit on neurological, behavioral, growth, or functional outcomes in their children at ...

Evaluate spontaneous intestinal perforation (SIP)/death among extremely low birthweight (ELBW) infants before, during and after initiation of an antenatal magnesium for neuroprotection protocol (MgPro ...

Magnesium sulphate protects very premature babies from cerebral palsy, a new study shows. The findings of this Cochrane Review could help reduce incidence of the disabling condition, which currently ...

A landmark international study in this week’s issue of THE LANCET highlights how magnesium sulphate can substantially reduce the chance of pregnant women who have pre-eclampsia developing the ...

Magnesium sulphate has garnered considerable attention as an effective adjuvant in perioperative pain management. Acting primarily as an N‐methyl‐d‐aspartate (NMDA) receptor antagonist, it disrupts ...